109 related articles for article (PubMed ID: 29038935)
1. Clinical knowledge of community pharmacists in Croatia for detecting drug-related problems.
Zekan L; Mestrovic A; Seselja Perisin A; Portolan M; Jambrek N; Jager S; Sepetavc M; Modun D
Int J Clin Pharm; 2017 Dec; 39(6):1171-1174. PubMed ID: 29038935
[TBL] [Abstract][Full Text] [Related]
2. Improving community pharmacists' clinical knowledge to detect and resolve drug-related problems in Croatia: a before/after survey study investigating the efficacy of an educational intervention.
Zekan L; Mestrovic A; Perisin AS; Bukic J; Leskur D; Rusic D; Modun D
BMJ Open; 2020 Jun; 10(6):e034674. PubMed ID: 32487573
[TBL] [Abstract][Full Text] [Related]
3. A clinical knowledge measurement tool to assess the ability of community pharmacists to detect drug-related problems.
Williams M; Peterson GM; Tenni PC; Bindoff IK
Int J Pharm Pract; 2012 Aug; 20(4):238-48. PubMed ID: 22775520
[TBL] [Abstract][Full Text] [Related]
4. Practical evaluation of the drug-related problem management process in Swiss community pharmacies.
Krähenbühl JM; Kremer B; Guignard B; Bugnon O
Pharm World Sci; 2008 Dec; 30(6):777-86. PubMed ID: 18392732
[TBL] [Abstract][Full Text] [Related]
5. Pharmacists' role in handling problems with prescriptions for antithrombotic medication in Belgian community pharmacies.
Desmaele S; De Wulf I; Dupont AG; Steurbaut S
Int J Clin Pharm; 2015 Aug; 37(4):656-68. PubMed ID: 25822042
[TBL] [Abstract][Full Text] [Related]
6. Survey of drug-related problems identified by community pharmacies.
Hämmerlein A; Griese N; Schulz M
Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
[TBL] [Abstract][Full Text] [Related]
7. Drug related problems identified by European community pharmacists in patients discharged from hospital.
Paulino EI; Bouvy ML; Gastelurrutia MA; Guerreiro M; Buurma H;
Pharm World Sci; 2004 Dec; 26(6):353-60. PubMed ID: 15683106
[TBL] [Abstract][Full Text] [Related]
8. Studying the impact of a medication use evaluation by the community pharmacist (Simenon): Drug-related problems and associated variables.
Wuyts J; Maesschalck J; De Wulf I; Lelubre M; Foubert K; De Vriese C; Boussery K; Goderis G; De Lepeleire J; Foulon V
Res Social Adm Pharm; 2020 Aug; 16(8):1100-1110. PubMed ID: 31759887
[TBL] [Abstract][Full Text] [Related]
9. Clinical medication reviews in elderly patients with polypharmacy: a cross-sectional study on drug-related problems in the Netherlands.
Chau SH; Jansen AP; van de Ven PM; Hoogland P; Elders PJ; Hugtenburg JG
Int J Clin Pharm; 2016 Feb; 38(1):46-53. PubMed ID: 26597955
[TBL] [Abstract][Full Text] [Related]
10. Community pharmacists' routine provision of drug-related problem-reduction services.
Al-Taani GM; Ayoub NM
PLoS One; 2022; 17(5):e0267379. PubMed ID: 35507568
[TBL] [Abstract][Full Text] [Related]
11. Use of point-of-service health status assessments by community pharmacists to identify and resolve drug-related problems in patients with musculoskeletal disorders.
Ernst ME; Doucette WR; Dedhiya SD; Osterhaus MC; Kumbera PA; Osterhaus JT; Townsend RJ
Pharmacotherapy; 2001 Aug; 21(8):988-97. PubMed ID: 11718502
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of criteria for classifying severity of drug-related problems in chronic kidney disease: A community pharmacy perspective.
Quintana-Bárcena P; Lord A; Lizotte A; Berbiche D; Jouini G; Lalonde L
Am J Health Syst Pharm; 2015 Nov; 72(21):1876-84. PubMed ID: 26490822
[TBL] [Abstract][Full Text] [Related]
13. Classification of drug-related problems with new prescriptions using a modified PCNE classification system.
Eichenberger PM; Lampert ML; Kahmann IV; van Mil JW; Hersberger KE
Pharm World Sci; 2010 Jun; 32(3):362-72. PubMed ID: 20229029
[TBL] [Abstract][Full Text] [Related]
14. Evaluating categorisation and clinical relevance of drug-related problems in medication reviews.
Granas AG; Berg C; Hjellvik V; Haukereid C; Kronstad A; Blix HS; Kilhovd B; Viktil KK; Horn AM
Pharm World Sci; 2010 Jun; 32(3):394-403. PubMed ID: 20407926
[TBL] [Abstract][Full Text] [Related]
15. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
Westerlund T; Marklund B
J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
[TBL] [Abstract][Full Text] [Related]
16. Promoting appropriate drug use through the application of the Spanish drug-related problem classification system in the primary care setting.
Gómez MA; Villafaina A; Hernández J; Salgado RM; González MA; Rodríguez J; Martínez de la Concha M; Tarriño A; Gervasini G; Carrillo JA
Ann Pharmacother; 2009 Feb; 43(2):339-46. PubMed ID: 19193590
[TBL] [Abstract][Full Text] [Related]
17. [Identifying and solving drug-related problems in terms of the community pharmacist].
Masaryková L; Fulmeková M; Lehocká L; Fazekaš T
Ceska Slov Farm; 2014 Feb; 63(1):32-9. PubMed ID: 24568336
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential drug-related problems in the elderly: the role of the community pharmacist.
Vinks TH; de Koning FH; de Lange TM; Egberts TC
Pharm World Sci; 2006 Feb; 28(1):33-8. PubMed ID: 16703267
[TBL] [Abstract][Full Text] [Related]
19. The status of the performance of medication reviews in German community pharmacies and assessment of the practical performance.
Greißing C; Kössler K; Freyer J; Hüter L; Buchal P; Schiek S; Bertsche T
Int J Clin Pharm; 2016 Dec; 38(6):1425-1435. PubMed ID: 27783313
[TBL] [Abstract][Full Text] [Related]
20. Drug-related problems detected in Australian Community Pharmacies: The PROMISe Trial.
Williams M; Peterson GM; Tenni PC; Bindoff IK; Curtain C; Hughes J; Bereznicki LR; Jackson SL; Kong DC; Hughes JD
Ann Pharmacother; 2011 Sep; 45(9):1067-76. PubMed ID: 21878658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
